Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AUPH

Aurinia Pharmaceuticals

$6.91

-0.63 (-8.36%)

, AGN

Allergan

$156.73

-3.55 (-2.21%)

10:31
01/22/19
01/22
10:31
01/22/19
10:31
On The Fly
Aurinia drops after Phase 2 trial results fail to meet primary endpoint »

Shares of Aurinia…

AUPH

Aurinia Pharmaceuticals

$6.91

-0.63 (-8.36%)

AGN

Allergan

$156.73

-3.55 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 18

    May

  • 28

    May

ALXN

Alexion

$113.31

-3.66 (-3.13%)

, AMGN

Amgen

$201.74

-2.18 (-1.07%)

10:24
01/22/19
01/22
10:24
01/22/19
10:24
On The Fly
Alexion slips on Soliris EU patent setback, though analysts see limited impact »

Shares of Alexion…

ALXN

Alexion

$113.31

-3.66 (-3.13%)

AMGN

Amgen

$201.74

-2.18 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

ALXN

Alexion

$116.97

2.32 (2.02%)

, AMGN

Amgen

$203.92

1.98 (0.98%)

09:39
01/22/19
01/22
09:39
01/22/19
09:39
Recommendations
Alexion, Amgen analyst commentary at Piper Jaffray »

Piper says Alexion should…

ALXN

Alexion

$116.97

2.32 (2.02%)

AMGN

Amgen

$203.92

1.98 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

AMGN

Amgen

$203.92

1.98 (0.98%)

09:04
01/22/19
01/22
09:04
01/22/19
09:04
Hot Stocks
Amgen: EC approves expanded indication for BLINCYTO monotherapy »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

AUPH

Aurinia Pharmaceuticals

$7.54

0.11 (1.48%)

, AGN

Allergan

$160.28

3.74 (2.39%)

07:16
01/22/19
01/22
07:16
01/22/19
07:16
Periodicals
Aurinia CEO says VOS could become blockbuster treatment, STATNews reports »

Though Aurinia…

AUPH

Aurinia Pharmaceuticals

$7.54

0.11 (1.48%)

AGN

Allergan

$160.28

3.74 (2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 18

    May

  • 28

    May

Friday
CSCO

Cisco

$44.21

0.25 (0.57%)

, ST

Sensata

$46.76

0.35 (0.75%)

08:09
01/18/19
01/18
08:09
01/18/19
08:09
Recommendations
Cisco, Sensata, Arista Networks analyst commentary at JPMorgan »

JPMorgan buyers of Cisco,…

CSCO

Cisco

$44.21

0.25 (0.57%)

ST

Sensata

$46.76

0.35 (0.75%)

ANET

Arista Networks

$221.09

0.02 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

  • 25

    Feb

  • 04

    Mar

Thursday
AGN

Allergan

$153.23

0.3 (0.20%)

10:25
01/17/19
01/17
10:25
01/17/19
10:25
Conference/Events
Leerink pharmaceuticals analysts to hold an analyst/industry conference call »

Pharmaceuticals Analysts,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 29

    Jan

  • 18

    May

  • 28

    May

AGN

Allergan

$152.93

0.27 (0.18%)

09:01
01/17/19
01/17
09:01
01/17/19
09:01
Conference/Events
Leerink pharmaceuticals analysts to hold an analyst/industry conference call »

Pharmaceuticals Analysts,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 18

    May

  • 28

    May

Over a week ago
AMGN

Amgen

$198.76

-0.63 (-0.32%)

17:44
01/16/19
01/16
17:44
01/16/19
17:44
Hot Stocks
Amgen, UCB receive positive FDA advisory committee vote for Evenity »

Amgen and UCB announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 28

    Jan

AMGN

Amgen

$198.52

-0.87 (-0.44%)

15:50
01/16/19
01/16
15:50
01/16/19
15:50
Periodicals
FDA advisors vote in favor of approval for Amgen's Evenity »

An FDA Advisory Committee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 28

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.